Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Obesity, the metabolic syndrome, and sexual dysfunction

International Journal of Impotence Research volume 17, pages 391–398 (2005)Cite this article

Abstract

Sexual problems in both sexes appear to be widespread in society, influenced by both health-related and psychosocial factors, and are associated with impaired quality of life. Epidemiological studies suggest that modifiable health behaviors, including physical activity and leanness, are associated with a reduced risk for erectile dysfunction (ED) among men. Data from other surveys also indicate a higher prevalence of impotence in obese men. Obesity may be a risk factor for sexual dysfunction in both sexes; the data for the metabolic syndrome are very preliminary and need to be confirmed in larger epidemiologic studies. The high prevalence of ED in patients with cardiovascular risk factors suggests that abnormalities of the vasodilator system of penile arteries play an important role in the pathophysiology of ED. We have shown that one-third of obese men with ED can regain their sexual activity after 2 y of adopting health behaviors, mainly regular exercise and reducing weight. Western societies actually spend a huge part of their health care costs on chronic disease treatment and interventions for risk factors. The adoption of healthy lifestyles can reduce the prevalence of obesity and the metabolic syndrome, and hopefully the burden of sexual dysfunction.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Braun M et al. Epidemiology of erectile dysfunction: results of the Cologne Male-Survey. Int J Impot Res 2000; 12: 305–311.

    Article  CAS  PubMed  Google Scholar 

  2. Laumann EO, Paik A, Rosen RC . Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281: 537–544.

    Article  CAS  PubMed  Google Scholar 

  3. Hopps CV, Mulhall JP . Novel agents for sexual dysfunction. BJU International 2003; 92: 534–538.

    Article  CAS  PubMed  Google Scholar 

  4. Berman J, Goldstein I . Female sexual dysfunction. Urol Clin North Am 2001; 28: 405–416.

    Article  CAS  PubMed  Google Scholar 

  5. National Center for Chronic Prevention and Health Promotion. Defining overweight and obesity. Available at: www.cdc.gov/nccdphp/dnpa/obesity/defining.htm. Accessed March 25 2005.

  6. Flegal KM et al. Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 1998; 22: 39–47.

    Article  CAS  PubMed  Google Scholar 

  7. Serdula MK et al. Prevalence of attempting weight loss and strategies for controlling weight. JAMA 1999; 282: 1353–1358.

    Article  CAS  PubMed  Google Scholar 

  8. National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med 2000; 160: 898–904.

  9. WHO. Obesity: Preventing and Managing the Global Epidemics. World Health Organization: Geneva, 1998.

  10. National Heart Lung and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. Obes Res 1998; 6 (Suppl 2): 51S–210S.

  11. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.

  12. Ford ES, Giles WH, Dietz WH . Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356–359.

    Article  PubMed  Google Scholar 

  13. Bacon CG et al. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med 2003; 139: 161–168.

    Article  PubMed  Google Scholar 

  14. Litwin MS, Nied RJ, Dhanani N . Health-related quality of life in men with erectile dysfunction. J Gen Intern Med 1998; 13: 159–166.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ventegodt S . Sex and quality of life in Denmark. Arch Sex Behav 1998; 27: 295–307.

    Article  CAS  PubMed  Google Scholar 

  16. Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 1994; 151: 54–61.

    Article  CAS  PubMed  Google Scholar 

  17. Carbone Jr DJ, Seftel AD . Erectile dysfunction. Diagnosis and treatment in older men. Geriatrics 2002; 57: 18–24.

    PubMed  Google Scholar 

  18. Johannes CB et al. Incidence of erectile dysfunction in men ages 40–69: longitudinal results from the Massachusetts male aging study. J Urol 2000; 163: 460–463.

    Article  CAS  PubMed  Google Scholar 

  19. Rosen R et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44: 637.

    Article  PubMed  Google Scholar 

  20. Pinnock CB, Stapleton AM, Marshall VR . Erectile dysfunction in the community: a prevalence study. Med J Aust 1999; 171: 353–357.

    CAS  PubMed  Google Scholar 

  21. Blanker MH et al. Correlates of erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J Am Geriatr Soc 2001; 49: 436–442.

    Article  CAS  PubMed  Google Scholar 

  22. Walczak MK et al. Prevalence of cardiovascular risk factors in erectile dysfunction. J Gend Specif Med 2002; 5: 19–24.

    PubMed  Google Scholar 

  23. Chung WS, Sohn JH, Park YY . Is obesity an underlying factor in erectile dysfunction? Eur Urol 1999; 36: 68–70.

    Article  CAS  PubMed  Google Scholar 

  24. Feldman HA et al. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 2000; 30: 328–338.

    Article  CAS  PubMed  Google Scholar 

  25. Fung MM, Bettencourt R, Barrett-Connor H . Heart disease risk factors predict erectile dysyears later. J Am Coll Cardiol 2004; 43: 1405–1411.

    Article  PubMed  Google Scholar 

  26. Feldman HA et al. Erectile dysfunction, cardiovascular disease and cardiovascular risk factors: prospective results in a large random sample of Massachusetts men. J Urol 1998; 159: 91.

    Article  Google Scholar 

  27. Calermajer DS et al. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interactions. J Am Coll Cardiol 1994; 24: 1468–1474.

    Article  Google Scholar 

  28. Esposito K et al. High proportions of erectile dysfunction in men with the metabolic sindrome. Diabetes Care 2005; 28: 1201–1203.

    Article  PubMed  Google Scholar 

  29. Frank E, Anderson C, Rubinstein D . Frequency of sexual dysfunction in normal couples. N Engl J Med 1978; 299: 111–115.

    Article  CAS  PubMed  Google Scholar 

  30. Rosen RC et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrunent for the assessment of female sexual function. J Sex Mar Ther 2000; 26: 191–208.

    Article  CAS  Google Scholar 

  31. Leiblum S et al. Vaginal atrophy in the postmenopausal woman: the importance of sexual activity and hormones. JAMA 1983; 249: 2195–2198.

    Article  CAS  PubMed  Google Scholar 

  32. Kirchengast S et al. Decreased sexual interest and its relationship to body build in postmenopausal women. Maturitas 1996; 23: 63–71.

    Article  CAS  PubMed  Google Scholar 

  33. Brody S . Slimness is associated with greater intercourse and lesser masturbation frequency. J Sex Mar Ther 2004; 30: 251–261.

    Article  Google Scholar 

  34. Kinzl JF et al. Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding. Obes Surg 2001; 11: 455–458.

    Article  CAS  PubMed  Google Scholar 

  35. Kapoor DS et al. Pelvic floor dysfunction in morbidly obese women: a pilot study. Obes Res 2004; 12: 1104–1107.

    Article  PubMed  Google Scholar 

  36. Esposito K et al. The metabolic syndrome: a cause of sexual dysfunction in women. Intern J Impot Res 2005; 17: 224–226.

    Article  CAS  Google Scholar 

  37. Khan MA et al for the Consensus Writing Committee. Second Consensus Conference on Cardiovascular Risk Factors and Erectile Dysfunction. Curr Med Res Opin 2002; 18: 33–35.

    Article  CAS  PubMed  Google Scholar 

  38. Solomon H, Man JW, Jackson G . Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 2003; 89: 251–253.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Virag R, Bouilly P, Frydman D . Is impotence an arterial disorder. A study of arterial risk factors in 440 impotent men. Lancet 1985; 1: 181–184.

    Article  CAS  PubMed  Google Scholar 

  40. O'Kane PD, Jackson G . Erectile dysfunction: is there silent obstructive coronary artery disease? Int J Clin Pract 2001; 55: 219–220.

    CAS  PubMed  Google Scholar 

  41. Blumentals WA et al. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Int J Impot Res 2004; 16: 350–353.

    Article  CAS  PubMed  Google Scholar 

  42. Kaiser DR et al. Impaired brachial artery endothelium-dependent and -independent vasodilation in man with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004; 43: 179–184.

    Article  PubMed  Google Scholar 

  43. Cheitlin MD . Eectile dysfunction. The earliest sign of generalized vascular disease? J Am Coll Cardiol 2004; 43: 185–186.

    Article  PubMed  Google Scholar 

  44. Kopelman PG . Obesity as a medical problem. Nature 2000; 404: 635–643.

    Article  CAS  PubMed  Google Scholar 

  45. Yudkin JS et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19: 972–978.

    Article  CAS  PubMed  Google Scholar 

  46. Bastard J-P et al. Elevated levels of interleukin-6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab 2000; 85: 3338–3342.

    CAS  PubMed  Google Scholar 

  47. Ziccardi P et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002; 105: 804–809.

    Article  CAS  PubMed  Google Scholar 

  48. Bhagat K, Balance P . Inflammatory cytokines impair endothelium dependent dilatation in human veins in vivo. Circulation 1997; 96: 3042–3047.

    Article  CAS  PubMed  Google Scholar 

  49. Romano M et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6: 315–325.

    Article  CAS  PubMed  Google Scholar 

  50. Kumada M et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85–89.

    Article  CAS  PubMed  Google Scholar 

  51. Lin Y et al. LPS activated TRL-4 receptor induces synthesis of the closely related receptor TRL-2 in adipocytes. J Biol Chem 2000; 275: 1104–1110.

    Google Scholar 

  52. Tracy RP et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 1997; 17: 2167–2176.

    Article  CAS  PubMed  Google Scholar 

  53. Festa A et al. Chronic subclinical inflammation as part of the insulin resistance syndrome. The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42–47.

    Article  CAS  PubMed  Google Scholar 

  54. Giugliano F et al. Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokines levels in obese men. J Endocrinol Invest 2004; 27: 665–669.

    Article  CAS  PubMed  Google Scholar 

  55. Saenz de Tejada I et al. Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl J Med 1989; 320: 1025–1030.

    Article  CAS  PubMed  Google Scholar 

  56. De Angelis L et al. Erectile dysfunction in type II diabetes: a possibile link. Diabetologia 2001; 44: 1155–1160.

    Article  CAS  PubMed  Google Scholar 

  57. Higdon JV, Frei B . Obesity and oxidative stress. A direct link to CVD? Arterioscler Thromb Vasc Biol 2003; 23: 365–367.

    Article  CAS  PubMed  Google Scholar 

  58. Esposito K, Giugliano D . The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 2004; 14: 228–232.

    Article  CAS  PubMed  Google Scholar 

  59. Roberts C, Vaziri ND, Barnard RJ . Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation 2002; 106: 2530–2532.

    Article  CAS  PubMed  Google Scholar 

  60. Verma S et al. A self-fulfilling prophecy: C-reactiveprotein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106: 913–919.

    Article  CAS  PubMed  Google Scholar 

  61. Bank AJ et al. Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction. Intern J Impot Res 2003; 15: 231–236.

    Article  CAS  Google Scholar 

  62. Blake GJ, Ridker PM . Novel clinical markers of vascular wall inflammation. Circ Res 2001; 89: 763–771.

    Article  CAS  PubMed  Google Scholar 

  63. Pasceri V, Willerson JT, Yeh ET . Direct proinflammatory effect of C-reactiveprotein on human endothelial cells. Circulation 2000; 102: 2165–2168.

    Article  CAS  PubMed  Google Scholar 

  64. Yeh ET et al. C-reactiveprotein: linking inflammation to cardiovascular complications. Circulation 2001; 104: 974–975.

    Article  CAS  PubMed  Google Scholar 

  65. Sullivan ME et al. Nitric oxide and penile erections: is erectile dysfunction another manifestation of vascular disease? Cardiovasc Res 1999; 43: 658–665.

    Article  CAS  PubMed  Google Scholar 

  66. Esposito K et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized trial. JAMA 2004; 291: 2978–2984.

    Article  CAS  PubMed  Google Scholar 

  67. Derby CA et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 2000; 56: 302–306.

    Article  CAS  PubMed  Google Scholar 

  68. Pate RR et al. Physical activity and public health : a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273: 402–407.

    Article  CAS  PubMed  Google Scholar 

  69. Esposito K et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 292: 1440–1446.

    Article  CAS  PubMed  Google Scholar 

  70. Ernst MD et al. Consistency between US dietary fat intake and serum total cholesterol concentrations: the National Health and Nutrition Examination Survey. Am J Clin Nutr 1997; 66: 965S–972S.

    Article  CAS  PubMed  Google Scholar 

  71. James WPT . A public health approach to the problem of obesity. Int J Obes Relat Metab Disord 1995; 19: S37–S45.

    PubMed  Google Scholar 

  72. Haskell WL . Physical activity, sport, and health: toward the next century. Res Q Exerc Sport 1996; 67: S37–S47.

    Article  CAS  PubMed  Google Scholar 

  73. Paffenbarger Jr RS et al. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986; 314: 605–613.

    Article  PubMed  Google Scholar 

  74. Manson JE et al. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N Engl J Med 1999; 341: 650–658.

    Article  CAS  PubMed  Google Scholar 

  75. Grundy SM et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the HAH Task Force on Risk Reduction. Circulation 1998; 97: 1876–1887.

    Article  CAS  PubMed  Google Scholar 

  76. Shephard RJ, Balady GJ . Exercise as cardiovascular therapy. Circulation 1999; 99: 963–972.

    Article  CAS  PubMed  Google Scholar 

  77. Niebauer J, Cooke JP . Cardiovascular effects of exercise: role of endothelial shear stress. J Am Coll Cardiol 1996; 28: 1652–1660.

    Article  CAS  PubMed  Google Scholar 

  78. Sessa WC et al. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 1994; 74: 349–353.

    Article  CAS  PubMed  Google Scholar 

  79. Hambrecht R et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000; 342: 454–460.

    Article  CAS  PubMed  Google Scholar 

  80. Esposito K, Marfella R, Giugliano D . Fitness versus fatness: the debate continues. Arterioscler Thromb Vasc Biol 2005; 25: e20–e21.

    CAS  PubMed  Google Scholar 

  81. Dusserre E, Moulin P, Vidal H . Differences in mRNA expression of the protein secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 2000; 1500: 88–96.

    Article  CAS  PubMed  Google Scholar 

  82. Arner P . Regional differences in protein production by human adipose tissue. Biochem Soc Trans 2001; 29: 72–75.

    Article  CAS  PubMed  Google Scholar 

  83. Kissebah AH, Krakower GR . Regional adiposity and morbidity. Physiol Rev 1994; 74: 761–811.

    Article  CAS  PubMed  Google Scholar 

  84. Lapidus L et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12-year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 1984; 289: 1257–1261.

    Article  CAS  Google Scholar 

  85. Hu FB et al. Television watching and other sedentary behaviours in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA 2003; 289: 1785–1791.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We wish to thank Dr Allen D Seftel for helpful criticism in reading the manuscript.

Author information

Authors and Affiliations

  1. Department of Geriatrics and Metabolic Diseases, University of Naples SUN, Naples, Italy

    K Esposito & D Giugliano

Authors
  1. K Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Giugliano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K Esposito.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Esposito, K., Giugliano, D. Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot Res 17, 391–398 (2005). https://doi.org/10.1038/sj.ijir.3901333

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijir.3901333

Keywords

This article is cited by

Search

Advanced search

Quick links